- 专利标题： Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Use
-
申请号： US15725253申请日： 2018-01-03
-
公开(公告)号： US20180100019A1公开(公告)日： 2018-04-12
- 发明人: Renata Lee , Vincent Mikol , Elizabeth Allen , Norman Ruetsch , Beatrice Cameron , Thomas Oligino , Nicholas Baurin
- 申请人： Sanofi
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; G06F19/12 ; A61K39/00
摘要：
The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders.
信息查询
